Neuphoria Therapeutics (NEUP) Common Equity (2020 - 2026)
Neuphoria Therapeutics (NEUP) posted Common Equity of $24.6 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 29.5% from $19 million a year earlier but down 16.4% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Common Equity (2020 - 2026) Analysis & Trends
Since fiscal Q4 2020, Neuphoria Therapeutics has reported Common Equity for 16 quarters.
- Annual Common Equity shows a five-year compound annual growth rate of -7.7% (FY2021 to FY2026).
- In prior fiscal years, Neuphoria Therapeutics' Common Equity was $19 million in FY2025 (+8.6%), $17.49 million in FY2024 (-20.5%), $22.01 million in FY2023 (-46.0%) and $40.76 million in FY2022 (+11.2%).
- Quarterly Common Equity has run from a low of $12.51 million in fiscal Q1 2026 to a high of $40.76 million in fiscal Q4 2022 over five years.
- On a year-over-year basis, Common Equity has increased in each of the last three quarters, with growth averaging 19.4% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was fiscal Q2 2026, with growth of 116.0%; the weakest was fiscal Q4 2023, with a decline of 45.7%.
- According to Business Quant data, Common Equity for the three prior fiscal quarters was $29.42 million (Q3 2026), $29.7 million (Q2 2026) and $12.51 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 24.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.60 Mn |
| Mar 31, 2026 | 29.42 Mn |
| Dec 31, 2025 | 29.70 Mn |
| Sep 30, 2025 | 12.51 Mn |
| Jun 30, 2025 | 19.00 Mn |
| Mar 31, 2025 | 26.00 Mn |
| Dec 31, 2024 | 13.75 Mn |
| Sep 30, 2024 | 17.07 Mn |
| Jun 30, 2024 | 17.49 Mn |
| Mar 31, 2024 | 17.95 Mn |
| Dec 31, 2023 | 19.50 Mn |
| Sep 30, 2023 | 17.23 Mn |
| Jun 30, 2023 | 22.15 Mn |
| Jun 30, 2022 | 40.76 Mn |
| Jun 30, 2021 | 36.65 Mn |
| Jun 30, 2020 | 8.31 Mn |
API Access
Neuphoria Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();